This brand name is authorized in Ireland, South Africa
The drug PHYLLOCONTIN contains one active pharmaceutical ingredient (API):
1
Aminophylline hydrate
UNII Y7E0LU9ZMS - AMINOPHYLLINE MONOHYDRATE
|
Aminophylline is a soluble derivative of theophylline and is given for its theophylline activity. Aminophylline relaxes smooth muscle and relieves bronchial spasm. It stimulates the myocardium and reduces venous pressure in congestive heart failure, leading to a marked increase in cardiac output. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
PHYLLOCONTIN CONTINUS Prolonged release tablets | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
R03DA05 | Aminophylline | R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DA Xanthines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: IE | Health Products Regulatory Authority | Identifier(s): 56296 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): J/10.2/127 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.